Task: Answer Verification
Input (English): Question: Do clinical events after cessation of lamivudine therapy in patients recovered from hepatitis B flare with hepatic decompensation?
Answer: Cessation of lamivudine therapy after recovery from hepatitis B flare with decompensation was safe for most patients. However, 8.2% develop decompensation within 1 year and can be rescued by timely retreatment. With close monitoring, the stopping strategy could be a feasible alternative to indefinite therapy, especially in low resource settings.
Output (English): yes